These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8360123)

  • 41. Mutation affecting resistance of Escherichia coli K12 to nalidixic acid.
    Hrebenda J; Heleszko H; Brzostek K; Bielecki J
    J Gen Microbiol; 1985 Sep; 131(9):2285-92. PubMed ID: 3906038
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Post-UV survival of Escherichia coli strains carrying more than one UV-sensitising plasmid.
    Ambler JE; Pinney RJ
    Mutat Res; 1996 Apr; 351(2):181-6. PubMed ID: 8622712
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A 4-kilobase congo red binding plasmid DNA fragment of Shigella dysenteriae 1 suppresses the growth and cell differentiation in Escherichia coli.
    Biswas D; Shaikh NM; Ghosh AN; Kumar R
    Acta Microbiol Hung; 1992; 39(2):203-6. PubMed ID: 1307443
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Replication of the deoxyribonucleic acid of multiple-drug-resistance factor in Escherichia coli.
    Barker GR; Hardman N; Twose TM
    Biochem J; 1976 Jul; 157(1):221-7. PubMed ID: 786280
    [TBL] [Abstract][Full Text] [Related]  

  • 45. R-plasmid transfer and its response to nalidixic acid.
    Burman LG
    J Bacteriol; 1977 Jul; 131(1):76-81. PubMed ID: 326773
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression of lipopolysaccharide O antigen in Escherichia coli K-12 hybrids containing plasmid and chromosomal genes from Shigella dysenteriae 1.
    Hale TL; Guerry P; Seid RC; Kapfer C; Wingfield ME; Reaves CB; Baron LS; Formal SB
    Infect Immun; 1984 Nov; 46(2):470-5. PubMed ID: 6389345
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Emergence of plasmid-mediated quinolone resistance in Escherichia coli in Europe.
    Mammeri H; Van De Loo M; Poirel L; Martinez-Martinez L; Nordmann P
    Antimicrob Agents Chemother; 2005 Jan; 49(1):71-6. PubMed ID: 15616277
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Plasmid profiles of Shigella dysenteriae type 1 isolates from Ethiopia with special reference to R-plasmids.
    Gebre-Yohannes A; Drasar BS
    J Med Microbiol; 1990 Oct; 33(2):101-6. PubMed ID: 2231675
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antibiotic resistance and conjugative R plasmids in clinical isolates of Enterobacteriaceae in Peninsular Malaysia.
    Koh CL
    Trans R Soc Trop Med Hyg; 1986; 80(1):158-61. PubMed ID: 3726978
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Constitutive error-prone repair at sites of excision repair in Escherichia coli: a re-examination.
    Bridges BA; Southworth M
    Biochimie; 1982; 64(8-9):655-9. PubMed ID: 6814513
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Laboratory surveillance of Shigella dysenteriae type 1 in KwaZulu-Natal.
    Karas JA; Pillay DG; Naicker T; Sturm AW
    S Afr Med J; 1999 Jan; 89(1):59-63. PubMed ID: 10070415
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Effect of R-factors on the sensitivity of Shigella sonnei to nalidixic acid].
    Sivolodskii EP
    Antibiotiki; 1976 Dec; 21(12):1085-9. PubMed ID: 798548
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Drug resistance of the causative agent of Grigo'rev-Shiga dysentery (Shigella dysenteriae 1)isolated in the USSR].
    Solodovnikov IuP; Iakovleva ON; Slankovskaia GS
    Antibiot Khimioter; 1989 Oct; 34(10):745-8. PubMed ID: 2694989
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Survival of recombination-deficient mutants of Escherichia coli during incubation with nalidixic acid.
    McDaniel LS; Rogers LH; Hill WE
    J Bacteriol; 1978 Jun; 134(3):1195-8. PubMed ID: 350844
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Resistance of shigella to nalidixic acid & fluorinated quinolones.
    Thirunarayanan MA; Jesudason MV; John TJ
    Indian J Med Res; 1993 Nov; 97():239-41. PubMed ID: 8144205
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genetic and biophysical study of R plasmids conferring sulfonamide resistance in Shigella strains isolated in 1952 and 1956.
    Davey RB; Pittard J
    J Bacteriol; 1974 Dec; 120(3):1186-95. PubMed ID: 4215794
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Occurrence in Sudan of Shigella dysenteriae type 1 with transferable antimicrobial resistance.
    Musa HA; Hassan HS; Shears P
    Ann Trop Med Parasitol; 1997 Sep; 91(6):669-71. PubMed ID: 9425371
    [No Abstract]   [Full Text] [Related]  

  • 58. A mutant of Escherichia coli hyper-resistant to a number of DNA damaging agents: location of the mutational site.
    Ahmad SI
    J Photochem Photobiol B; 1996 Oct; 36(1):47-53. PubMed ID: 8988611
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mode of incomplete cross-resistance among pipemidic, piromidic, and nalidixic acids.
    Inoue S; Ohue T; Yamagishi J; Nakamura S; Shimizu M
    Antimicrob Agents Chemother; 1978 Aug; 14(2):240-5. PubMed ID: 358918
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nalidixic acid-resistant mutations of the gyrB gene of Escherichia coli.
    Yamagishi J; Yoshida H; Yamayoshi M; Nakamura S
    Mol Gen Genet; 1986 Sep; 204(3):367-73. PubMed ID: 3020376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.